Menopause (Wechseljahre) involves a decline in estrogen, which can reduce insulin sensitivity and increase the risk of metabolic syndrome and type 2 diabetes. Key markers to monitor include fasting glucose, HbA1c, and possibly fasting insulin – ideally through clinical lab work. Direct-to-consumer tests (e.g., MyBody-X) may measure insulin but are not diagnostic and should not guide self-treatment or supplementation without medical supervision. Lifestyle factors (diet, exercise, stress management) have a greater impact than single biomarkers. The evidence linking insulin resistance and menopause is solid (human-moderate), but interpretation of home tests remains uncertain. Caveat: None of the provided sources directly address this topic; the answer is based on general medical knowledge.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-f91ab52765f04242a597814f